- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00024921
The Genetics of Kidneys in Diabetes (GoKinD) Study
September 5, 2013 updated by: National Center for Research Resources (NCRR)
Kidney disease in diabetes (diabetic nephropathy) tends to run in families.
It is likely, therefore, that there are genes that predict or are associated with either getting or not getting diabetic nephropathy.
The GoKinD Study will provide clinical information and DNA for investigators to look for these genes.
Evaluation will be performed and DNA obtained from approximately 1100 diabetic persons with kidney disease and 1000 diabetic persons without kidney disease.
In some cases, samples for DNA will also be obtained from the parents of these subjects.
Clinical information and DNA will be coded so that individuals cannot be identified, but the DNA can be linked to the clinical data from the individual.
Multiple investigators will be able to use this genetic material to test hypotheses about the genetics of kidney disease in diabetes.
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Anticipated)
2100
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Missouri
-
St. Louis, Missouri, United States, 63110
- Washington University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 54 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion criteria:
Type 1 diabetes mellitus with or without diabetic nephropathy; 19-54 years old; no other kidney disease
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Registration Dates
First Submitted
October 5, 2001
First Submitted That Met QC Criteria
October 9, 2001
First Posted (Estimate)
October 10, 2001
Study Record Updates
Last Update Posted (Estimate)
September 6, 2013
Last Update Submitted That Met QC Criteria
September 5, 2013
Last Verified
December 1, 2003
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- NCRR-M01RR00036-0805
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetic Nephropathy
-
Zheng GuoNot yet recruitingDiabetic Nephropathy Type 2
-
The Third Xiangya Hospital of Central South UniversityCompletedType 2 Diabetic NephropathyChina
-
Centro Universitario de Ciencias de la Salud, MexicoUnknownDiabetic Nephropathy Type 2Mexico
-
Assiut UniversityUnknownDiabetic Nephropathy Type 2
-
University of Sao Paulo General HospitalCompleted
-
Second Affiliated Hospital, School of Medicine,...Second Affiliated Hospital of Wenzhou Medical University; Lishui Country People...RecruitingDiabetic Nephropathy Type 2 | BiomarkerChina
-
Chinese PLA General HospitalCompletedInsulin Pump Therapy in Treating Diabetic Nephropathy
-
Assiut UniversityNot yet recruitingType 2 DM é Diabetic Nephropathy
-
PfizerTerminatedType 2 Diabetic NephropathyUnited States
-
Chang Gung Memorial HospitalUnknown